Regulation of the insulin-like growth factor axis by increasing cell number in intestinal epithelial (IEC-6) cells

被引:7
作者
Corkins, MR
Park, JHY
Davis, DV
Slentz, DH
MacDonald, RG
机构
[1] Univ Nebraska, Med Ctr, Creighton Univ, Dept Pediat,Div Pediat Gastroenterol, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[3] Hallym Univ, Dept Food & Nutr, Chunchon, South Korea
关键词
IGF-I; IGF-II; cellular density; IGFBP-2; IEC-6; intestinal epithelium;
D O I
10.1054/ghir.1999.0119
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Insulin-like growth factor binding protein-2 (IGFBP-2) production as a function of cell number by intestinal epithelial cells (IEC-6) was regulated such that the IGFBP-2 concentration in 24-h conditioned medium reached a maximum, which was maintained despite increasing cell number. Northern blot analysis revealed that this effect could largely be attributed to decreasing IGFBP-2 mRNA. In contrast to IGFBP-2, secretion of IGF-II and accumulation of IGF-II mRNA by IEC-6 cells correlated positively with cell number. The highest level of IGF-II protein detected by immunoblotting of conditioned medium occurred in post-confluent cells. IGF-I stimulated the cells to grow to a high cellular density and inhibited IGFBP-2 secretion in a concentration-dependent fashion. We conclude that expression of IGF-II and IGFBP-2 are regulated in IEC-6 cells by cellular density, and IGF-II may act as a survival factor at high cell density. (C) 1999 Harcourt Publishers Ltd.
引用
收藏
页码:414 / 424
页数:11
相关论文
共 41 条
[1]  
[Anonymous], 1997, BIOCH BIOPHYSICA ACT
[2]   Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix [J].
Arai, T ;
Busby, W ;
Clemmons, DR .
ENDOCRINOLOGY, 1996, 137 (11) :4571-4575
[3]   REGULATION OF INTESTINAL EPITHELIAL-CELL GROWTH BY TRANSFORMING GROWTH-FACTOR TYPE-BETA [J].
BARNARD, JA ;
BEAUCHAMP, RD ;
COFFEY, RJ ;
MOSES, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1578-1582
[4]   CIRCULATING BINDING-PROTEINS FOR THE INSULIN-LIKE GROWTH-FACTORS [J].
BAXTER, RC .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1993, 4 (03) :91-96
[5]  
BRASAEMLE DL, 1988, BIOTECHNIQUES, V6, P418
[6]   Orally administered IGF-I increases intestinal mucosal growth in formula-fed neonatal pigs [J].
Burrin, DG ;
Wester, TJ ;
Davis, TA ;
Amick, S ;
Heath, JP .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 270 (05) :R1085-R1091
[7]   SECRETION AND BIOLOGICAL ACTIONS OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN 2 HUMAN TUMOR-DERIVED CELL-LINES INVITRO [J].
CAMACHOHUBNER, C ;
MCCUSKER, RH ;
CLEMMONS, DR .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 148 (02) :281-289
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   THE INSULIN-LIKE GROWTH-FACTORS [J].
COHICK, WS ;
CLEMMONS, DR .
ANNUAL REVIEW OF PHYSIOLOGY, 1993, 55 :131-153
[10]   GLYCOSYLATION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3) IS NOT REQUIRED FOR POTENTIATION OF IGF-I ACTION - EVIDENCE FOR PROCESSING OF CELL-BOUND IGFBP-3 [J].
CONOVER, CA .
ENDOCRINOLOGY, 1991, 129 (06) :3259-3268